New Horizon Health Ltd
HKEX:6606
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (54), the stock would be worth HK$14.85 (5% upside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 51.5 | HK$14.14 |
0%
|
| 3-Year Average | 54 | HK$14.85 |
+5%
|
| 5-Year Average | 52.6 | HK$14.44 |
+2%
|
| Industry Average | 33.5 | HK$9.21 |
-35%
|
| Country Average | 29.6 | HK$8.14 |
-42%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
HK$6.5B
|
/ |
Jul 2023
¥110.6m
|
= |
|
|
HK$6.5B
|
/ |
Dec 2023
¥108.3m
|
= |
|
|
HK$6.5B
|
/ |
Dec 2024
¥113.1m
|
= |
|
|
HK$6.5B
|
/ |
Dec 2025
¥528.2m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CN |
|
New Horizon Health Ltd
HKEX:6606
|
6.5B HKD | 51.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
105.9B USD | 59.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
76.6B USD | 12.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 22.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 21.1 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.1B USD | 24.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | -27.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 14.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 17.1 |
| Median | 29.6 |
| 70th Percentile | 57.7 |
| Max | 43 569.3 |
Other Multiples
New Horizon Health Ltd
Glance View
New Horizon Health Ltd. operates as an investment holding company. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-02-18. The firm distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Company’s Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.
